Search results
Results From The WOW.Com Content Network
18,000 (2023) [1] Website. lonza .com. Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
July 25, 2024 at 3:19 AM. By Isabel Demetz and Andrey Sychev. (Reuters) -Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a ...
Lonza Group Ltd (VTX:LONN) saw a double-digit share price rise of over 10% in the past couple of months on the SWX...
Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Eppendorf, a company with its registered office in Germany, develops, produces and sells products and services for laboratories around the world. Eppendorf products are used in academic and industrial research laboratories, e.g. in companies in the pharmaceutical, biotech, chemical and food industries. They are also used in laboratories that ...
Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets ...
The stock of Lonza Group (OTCPK:LZAGY, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.
Language links are at the top of the page across from the title.